Real-life cost-effectiveness of benralizumab in patients with severe asthma

BACKGROUND: Availability of clinically effective and cost-effective treatments for severe asthma would be beneficial to patients and national healthcare systems. The aim of this study was to evaluate clinical outcomes and healthcare expenditure after incorporating benralizumab into the standard trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Padilla-Galo, A., García-Ruiz, A. J., Levy Abitbol, R. Ch., Olveira, C., Rivas-Ruiz, F., García-Agua Soler, N., Pérez Morales, M., Valencia Azcona, B., Tortajada-Goitia, B., Moya-Carmona, I., Levy-Naon, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155800/
https://www.ncbi.nlm.nih.gov/pubmed/34044819
http://dx.doi.org/10.1186/s12931-021-01758-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155800/
https://www.ncbi.nlm.nih.gov/pubmed/34044819
http://dx.doi.org/10.1186/s12931-021-01758-0

Ejemplares similares